# Ready-to-Use Imaging Agents Sagent Simplifies Fluorescence-Guided Imaging With Zyogreen By Mursal Rahman | Written with AI assistance | Published 2026-09-23 | Lifestyle Source: Trend Hunter, https://www.trendhunter.com/trends/fluorescence-imaging-solution References: [prnewswire](https://www.prnewswire.com/news-releases/sagent-pharmaceuticals-launches-zyogreen-the-first-and-only-ready-to-use-indocyanine-green-injection-in-the-us-302886637.html)  Sagent Pharmaceuticals is expanding ready-to-use imaging agents with Zyogreen, an FDA-approved indocyanine green injection supplied as a sterile solution that requires no reconstitution. Conventional ICG products are typically provided as lyophilized powders that clinicians must prepare before administration. Zyogreen removes this step while supporting [fluorescence-guided procedures and diagnostic imaging](https://www.trendhunter.com/trends/medical-imagings) across vascular, gastrointestinal, transplant, reconstructive, gynecologic, and [ophthalmic applications](https://www.trendhunter.com/trends/zeiss-medical-technology). The product is commercially available through Sagent’s U.S. distribution network. For Sagent, the launch expands its specialty pharmaceutical portfolio while addressing workflow efficiency for hospitals and surgical teams. The ready-to-use format could reduce preparation demands and make ICG more convenient to incorporate into clinical workflows. Zyogreen also joins Bludigo in Sagent’s [surgical and diagnostic visualization portfolio](https://www.trendhunter.com/trends/imaging-biomarkers), giving the company a broader presence in medical dyes while its partnership with Provepharm supports nationwide distribution and product availability. Image Credit: Sagent Pharmaceuticals ## Trend Insights (Trend Hunter) - Score: 6.1/10 - Popularity: 39% | Activity: 51% | Freshness: 92% - Audience gender: 50% men, 50% women - Primary generations: Millennial, Gen X - Top markets: North America ## Categories [Trend Hunter](https://www.trendhunter.com/trends) > [Lifestyle](https://www.trendhunter.com/lifestyle) > [Health](https://www.trendhunter.com/health) ## Key Themes ### Why This Trend Is Growing - **Ready-to-use Injectables:** Pre-prepared sterile formulations reduce pharmacy handling steps and create openings for differentiated hospital products built around speed, consistency, and lower preparation complexity. - **Fluorescence-guided Surgery:** Expanded use of imaging dyes in operating rooms is reshaping procedural visibility, enabling new combinations of diagnostics, surgical tools, and specialty pharmaceuticals. - **Workflow-centric Pharmaceuticals:** Medication formats designed around clinical efficiency highlight a shift toward products that compete on operational value as much as therapeutic performance. ### Industries Being Reshaped - **Specialty Pharmaceuticals:** Companies in niche injectable and diagnostic portfolios can use formulation convenience as a point of separation in mature clinical categories. - **Medical Imaging:** Demand for real-time visualization in surgery and diagnostics supports growth in agent-device ecosystems that improve precision across multiple specialties. - **Hospital Supplies:** Sterile, ready-to-administer products reflect an opportunity for suppliers to address staff constraints, reduce preparation variability, and simplify procedural logistics. ## Related on Trend Hunter - [Revolutionary Medical Imaging Systems](https://www.trendhunter.com/trends/medical-imaging-systems.md) - [Next-Generation Medical Imaging Devices](https://www.trendhunter.com/trends/medical-imaging-devices.md) - [Biotech-Formulated Gut Health Supplements](https://www.trendhunter.com/trends/cellular-nutrition1.md) - [Deep-Learning Image Reconstruction Tools](https://www.trendhunter.com/trends/image-reconstruction.md) - [Pharmaceutical-Grade Cannabis Companies](https://www.trendhunter.com/trends/green-revolution.md) - [Flexible Digital Radiography Systems](https://www.trendhunter.com/trends/handles-routine-imaging.md)